Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

132.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.4K
Neurotransmitters01:31

Neurotransmitters

2.9K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.9K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

18.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.1K
Bulimia Nervosa01:30

Bulimia Nervosa

840
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
840
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Retraction notice to "P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of NMDA-glutamate and acetylcholine receptors during neuronal differentiation". [Neuroscience 146 (2007) 1169-1181].

Neuroscience·2025
Same author

PFAS screening in municipal wastewater effluents and mixed liquor - using TOP assay as a sum parameter.

Chemosphere·2025
Same author

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

British journal of pharmacology·2023
Same author

Novel PFAS-specific monitoring approach for highly impacted surface waters.

Chemosphere·2023
Same author

Purinergic system in cancer stem cells.

Purinergic signalling·2023

Related Experiment Video

Updated: Feb 22, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K

Purinergic system in psychiatric diseases.

A Cheffer1, A R G Castillo1, J Corrêa-Velloso1

  • 1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.

Molecular Psychiatry
|September 27, 2017
PubMed
Summary

The purinergic system plays a crucial role in psychiatric disorders like depression and schizophrenia. Understanding its function offers new therapeutic targets for these debilitating conditions.

More Related Videos

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
08:38

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

Published on: September 1, 2011

75.8K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.7K

Related Experiment Videos

Last Updated: Feb 22, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
08:38

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

Published on: September 1, 2011

75.8K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.7K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Psychiatric disorders affect over 80 million globally.
  • Current treatments manage symptoms, not causes.
  • The purinergic system is implicated in psychiatric disorder biology.

Purpose of the Study:

  • To review the purinergic system's role in psychiatric disorders.
  • To focus on depression, schizophrenia, bipolar disorder, autism, and ADHD.
  • To explore how psychiatric medications interact with the purinergic system.

Main Methods:

  • Comprehensive literature search.
  • Analysis of purinergic system function.
  • Review of therapeutic mechanisms.

Main Results:

  • The purinergic system is involved in the development and predisposition to psychiatric disorders.
  • Specific purinergic pathways are linked to depression, schizophrenia, bipolar disorder, autism, and ADHD.
  • Existing psychiatric therapeutics modulate the purinergic system.

Conclusions:

  • The purinergic system is a key target for understanding and treating psychiatric disorders.
  • Further research into purinergic signaling could yield novel therapeutic strategies.
  • Targeting the purinergic system offers potential for more effective psychiatric treatments.